Last reviewed · How we verify
Dexmedetomidine and propofol
Dexmedetomidine and propofol are combined sedative agents that work synergistically to produce sedation and anesthesia through alpha-2 adrenergic receptor agonism and GABA-A receptor potentiation, respectively.
Dexmedetomidine and propofol are combined sedative agents that work synergistically to produce sedation and anesthesia through alpha-2 adrenergic receptor agonism and GABA-A receptor potentiation, respectively. Used for Sedation in intensive care units, Procedural sedation, Perioperative sedation and anesthesia.
At a glance
| Generic name | Dexmedetomidine and propofol |
|---|---|
| Also known as | Precedex, Diprivan, Dexmedetomidine Hydrochloride injection and propofol injectable emulsion, DEX+PR, DxPr |
| Sponsor | Ain Shams University |
| Drug class | Sedative-hypnotic combination |
| Target | Alpha-2 adrenergic receptor (dexmedetomidine); GABA-A receptor (propofol) |
| Modality | Small molecule |
| Therapeutic area | Anesthesia and Sedation |
| Phase | FDA-approved |
Mechanism of action
Dexmedetomidine is a selective alpha-2 adrenergic agonist that produces sedation, analgesia, and anxiolysis by activating presynaptic and postsynaptic alpha-2 receptors in the central nervous system. Propofol is a GABA-A receptor positive allosteric modulator that enhances inhibitory neurotransmission, producing rapid sedation and hypnosis. The combination leverages complementary mechanisms to achieve balanced sedation with potentially reduced dosing requirements for each agent.
Approved indications
- Sedation in intensive care units
- Procedural sedation
- Perioperative sedation and anesthesia
Common side effects
- Hypotension
- Bradycardia
- Respiratory depression
- Injection site pain
- Hypertension (rebound)
Key clinical trials
- The Relationship Between Opioid-Free Anesthesia and Postoperative Agitation-Delirium and Quality of Recovery in Pediatric Ear, Nose, and Throat Cases Monitored With Perioperative Bispectral Index
- Awareness Neuraxial Versus General Anesthesia in Frail Patients Undergoing Laparoscopic or Robotic Abdominopelvic Surgery. (NA)
- Dexmedetomidine for Improving Emergence Quality in Thyroid Surgery (PHASE4)
- Comparison of Anesthetic Techniques for Early Recovery After Ankle Arthroscopy (NA)
- Tubeless Strategy in Lung Transplantation: A Prospective Single-Arm Study (NA)
- Opioid-Free vs Opioid-Based Anesthesia in Bariatric Surgery (NA)
- Comparison Between Two Drugs in Sedation of Upper GI Endoscopy
- Transition From Acute to Chronic Opioid Use and Chronic Pain (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dexmedetomidine and propofol CI brief — competitive landscape report
- Dexmedetomidine and propofol updates RSS · CI watch RSS
- Ain Shams University portfolio CI